Specialty Enzymes Market by Source (Microorganism, Plant, Animal), Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases), Application (Pharmaceuticals, Diagnostics, Research & Biotechnology), Form & Region - Global Forecast to 2029
상품코드:1509565
리서치사:MarketsandMarkets
발행일:2024년 07월
페이지 정보:영문 295 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계 특수 효소 시장 규모는 2024년에 61억 달러로 추정되고, 2029년에는 92억 달러에 이를 것으로 예측되고 있으며, 예측기간 중 CAGR은 금액 기준으로 8.5%가 될 것으로 보입니다.
생체분자에서 복잡한 당 사슬을 절단하는 능력은 특이성이 높은 진단 도구의 개발에 엄청난 잠재력을 가지고 있습니다. 예를 들어, 탄수화물 분해 효소는 병원체의 특이적인 당쇄 서명을 표적화할 수 있어 감염의 신속하고 정확한 확인을 가능하게 합니다. 또한 특정 질병과 관련된 특이적인 당 사슬 마커를 분석하여보다 조기 및 정확한 진단을 도울 수 있습니다. 맞춤형 의료에 대한 주목이 높아지는 가운데, 탄수화물 분해 효소는 개인의 요구에 부응하는 진단법의 개발에 있어서 독자적인 강점을 발휘해, 진단 검사의 장래에 있어서 그 존재감을 확고하게 하고 있습니다.
조사 범위
조사 대상년도
2024-2029년
기준년
2023년
예측 기간
2024-2029년
검토 단위
금액(달러)
부문별
유형별, 형태별, 유래별, 용도별, 지역별
대상 지역
북미, 유럽, 아시아태평양, 남미 및 기타 지역
미생물은 특히 연구·바이오테크놀러지에 있어서 다양한 용도에 이상적인 자질을 가지고 있기 때문에 특수 효소 시장의 유래 카테고리로 톱에 군림하고 있습니다. 박테리아와 곰팡이와 같은 미생물은 제어된 환경에서 쉽게 배양할 수 있어 대량의 효소를 확장 가능하고 비용 효율적으로 생산할 수 있습니다. 이것은 실험에 안정한 효소 공급이 필요한 연구에 매우 중요합니다. 미생물의 방대한 유전적 다양성은 매우 특이적인 기능을 가진 효소의 보고입니다. 과학자들은 이러한 효소를 활용하여 연구 및 생명 공학에서 필수적인 놀라운 정확도로 생체 분자를 조작 할 수 있습니다. 예를 들어, 미생물 효소는 DNA의 특정 부분을 선택적으로 절단하는데 사용될 수 있으며, 새로운 치료법 및 치료법의 창조에 필수적인 유전자 편집 기술을 용이하게 합니다. 게다가, 미생물은 유전자 재조합을 통해 새로운 특성을 가진 효소를 생산할 수 있어 연구 활동의 가능성을 더욱 넓힐 수 있습니다. 이러한 타의 추종을 불허하는 다양성과 적응성을 통해 미생물 유래의 효소는 연구 및 생명 공학 분야에서 특수 효소 시장의 주요 유래로 확고한 지위를 구축하고 있습니다.
유럽은 확립된 건강 관리 인프라를 자랑하며 특수 효소 산업에 대한 정부의 지원도 강력합니다. 이 때문에 특수효소를 이용한 치료를 포함한 혁신적인 치료에 대한 수요가 높아지고 있습니다. 유럽에서는 노화가 진행되고 있으며 만성 질환에 대한 효소 기반 치료 시장이 형성되고 있습니다. 게다가 지속가능한 실천에 대한 주목이 높아지고 있으며, 특수효소는 다양한 산업에서 기존의 화학촉매를 대체하는 보다 친환경적인 선택을 제공합니다. 또한 유럽의 효소 제조업체와 연구 기관 간의 협업이 시장 성장을 가속화하고 있습니다. 예를 들어 CORDIS-EU의 연구 결과에 따르면 2023년 12월에 시작된 EU 투자의 FuturEnzyme 프로젝트는 친환경 소비자를 위한 저비용 효소 개발을 목표로 하고 있습니다. 혁신적인 솔루션과 공동 작업을 통해 2025년 5월까지 효소의 발견과 최적화를 위해 약 67억 달러를 받을 예정입니다.
본 보고서에서는 세계의 특수효소 시장에 대해 조사했으며, 유형별, 형태별, 유래별, 용도별, 지역별 동향 및 시장 진출기업 프로파일 등을 정리했습니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 중요 인사이트
제5장 시장 개요
소개
거시경제지표
시장 역학
제6장 업계 동향
소개
공급망 분석
밸류체인 분석
무역 분석
기술 분석
가격 분석
에코시스템
고객의 비즈니스에 영향을 미치는 동향/혼란
특허 분석
2024-2025년의 주된 회의와 이벤트
규제 상황
Porter's Five Forces 분석
주요 이해관계자와 구매 기준
사례 연구
투자와 자금조달 시나리오
제7장 특수 효소 시장(유형별)
소개
탄수화물 분해 효소
프로테아제
리파제
폴리머라제와 뉴클레아제
기타
제8장 특수 효소 시장(형태별)
소개
액체
건조
제9장 특수 효소 시장(유래별)
소개
미생물
식물
동물
제10장 특수 효소 시장(용도별)
소개
의약품
연구와 생명공학
진단
생체촉매
제11장 특수 효소 시장(지역별)
소개
북미
유럽
아시아태평양
남미
기타 지역
제12장 경쟁 구도
개요
주요 진입기업의 전략/비책
수익 분석
시장 점유율 분석, 2023년
기업이치평가와 재무지표
브랜드/제품 비교
기업평가 매트릭스: 주요 진입기업, 2023년
기업평가 매트릭스: 스타트업/중소기업, 2023년
경쟁 시나리오와 동향
제13장 기업 프로파일
주요 진출기업
BRAIN BIOTECH AG
NOVOZYMES A/S
CODEXIS, INC.
SANOFI
MERCK KGAA
DYADIC INTERNATIONAL INC.
ADVANCED ENZYME TECHNOLOGIES
AMANO ENZYME INC.
F. HOFFMANN-LA ROCHE LTD.
NEW ENGLAND BIOLABS
BBI SOLUTIONS
CREATIVE ENZYMES
BIOSEUTICA
SEKISUI DIAGNOSTICS
ANTOZYME BIOTECH PVT. LTD.
기타 기업
SI BIOZYME
AUMGENE BIOSCIENCES
ENZYME BIOSCIENCE
INFINITA BIOTECH PRIVATE LIMITED
BIOLAXI ENZYMES PVT. LTD.
FIDO PHARMA PVT. LTD.
4BASEBIO
ANSEL BIOTECH
GENO TECHNOLOGY INC.
GUJARAT ENZYME
제14장 인접 시장과 관련 시장
제15장 부록
JHS
영문 목차
영문목차
According to MarketsandMarkets, the global Specialty enzymes market size is estimated to be valued at USD 6.1 billion in 2024 and is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5%, during the forecast period in terms of value. Their ability to cleave complex carbohydrates on biomolecules holds immense potential for developing highly specific diagnostic tools. For instance, carbohydrases can be used to target specific sugar signatures on pathogens, enabling rapid and accurate identification of infectious diseases. Additionally, they can be employed to analyze specific carbohydrate markers associated with certain illnesses, aiding in earlier and more precise diagnoses. As the focus on personalized medicine intensifies, carbohydrases offer a unique edge in developing diagnostics that cater to individual needs, solidifying their prominence in the future of diagnostic testing.
Scope of the Report
Years Considered for the Study
2024-2029
Base Year
2023
Forecast Period
2024-2029
Units Considered
Value (USD)
Segments
By Type, By Source, By application, By Form and Region.
Regions covered
North America, Europe, Asia Pacific, South America, and Rest of the World
" By source, Microorganisms are estimated to dominate the market during the forecast period."
Microorganisms reign supreme in the source category of the specialty enzyme market due to their ideal qualities for various applications, particularly in research & biotechnology. Microbes like bacteria and fungi can be easily cultivated in controlled environments, allowing for scalable and cost-effective production of large enzyme quantities. This is crucial for research where consistent enzyme supplies are needed for experiments. The vast genetic diversity of microbes offers a treasure trove of enzymes with highly specific functions. Scientists can harness these enzymes to manipulate biomolecules with incredible precision, a necessity in research & biotechnology. For example, microbial enzymes can be used to selectively cut specific sections of DNA, facilitating gene editing techniques vital for creating new treatments and therapies. Furthermore, microbes can be genetically modified to create enzymes with novel properties, further expanding their potential in research endeavors. This unmatched versatility and adaptability solidify microorganism-derived enzymes as the leading source for the specialty enzyme market in research & biotechnology.
"Europe will significantly contribute towards market growth during the forecast period."
Europe boasts a well-established healthcare infrastructure with strong government support for specialty enzyme industries. This translates to a high demand for innovative medical treatments, including those that utilize specialty enzymes. Europe's aging population creates a market for enzyme-based therapies for chronic diseases. Additionally, there's a growing focus on sustainable practices, and specialty enzymes offer a more eco-friendly alternative to traditional chemical catalysts in various industries. Furthermore, collaborations between European enzyme manufacturers and research institutions are accelerating market growth. For instance, According to CORDIS - EU research results, starting in December 2023, the EU-funded FuturEnzyme project aims to develop low-cost enzymes for eco-friendly consumers. Through innovative solutions and collaborative efforts, it will receive approximately USD 6.7 billion for enzyme discovery and optimization until May 2025.
Break-up of Primaries:
By Company Type: Tier1-40%, Tier 2-32%, Tier 3- 28%
By Designation: C-level-45%, D-level - 33%, and Others- 22%
By Region: North America - 15%, Europe - 20%, Asia Pacific - 40%, South America-12%, RoW - 13%,
Others include sales managers, territory managers, and product managers.
Leading players profiled in this report:
BRAIN Biotech AG (Germany)
Novozymes A/S (Denmark)
Codexis, Inc. (US)
Sanofi (France)
Merck KGaA (Germany)
Dyadic International Inc (US)
Advanced Enzyme Technologies (India)
Amano Enzyme Inc (Japan)
F. Hoffmann-La Roche Ltd (Switzerland)
New England Biolabs (US)
BBI Solutions (UK)
Creative Enzymes (US)
Bioseutica (Netherland)
SEKISUI Diagnostics (US)
Antozyme Biotech Pvt Ltd (India)
S.I. Biozyme (India)
Aumgene Biosciences (India)
enzymebiosciences (India)
Infinita Biotech Private Limited (India)
Biolaxi Corporation (India)
Fido Pharma Pvt. Ltd. (India)
4basebio (UK)
Ansel Biotech (India)
Geno Technology Inc. (US)
Gujarat Enzyme (India)
The study includes an in-depth competitive analysis of these key players in the specialty enzymes market with their company profiles, recent developments, and key market strategies.
Research Coverage:
The report segments the specialty enzymes market based on type, source, form, applications, and region. In terms of insights, this report has focused on various levels of analyses-the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the global specialty enzymes market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall specialty enzymes market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
Analysis of key drivers (Rise in Demand for Non-harmful Biological Catalysts in Pharmaceuticals & Diagnostics), restraints (Lack of Harmonization in the Regulatory Framework), opportunities (Lack of Harmonization in the Regulatory Framework), and challenges (Lack of Harmonization in the Regulatory Framework) influencing the growth of the specialty enzymes market.
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the specialty enzymes market.
Market Development: Comprehensive information about lucrative markets - the report analyses the specialty enzymes market across varied regions.
Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the specialty enzymes market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as BRAIN Biotech AG (Germany), Novozymes A/S (Denmark), Codexis, Inc. (US), Sanofi (France), Merck KGaA (Germany), Dyadic International Inc (US), and Advanced Enzyme Technologies (India) among others in the specialty enzymes market strategies. The report also helps stakeholders understand the specialty enzymes market and provides them with information on key market drivers, restraints, challenges, and opportunities.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
FIGURE 1 MARKET SEGMENTATION
1.3.1 REGIONS COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES, 2020-2023
1.6 UNIT CONSIDERED
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 SPECIALTY ENZYMES MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY SPECIALTY ENZYME MANUFACTURER, DESIGNATION, AND REGION
2.2 FACTOR ANALYSIS
2.2.1 INTRODUCTION
2.2.2 DEMAND-SIDE ANALYSIS
FIGURE 4 KEY ECONOMIES BASED ON GDP, 2020-2023 (USD BILLION)
2.2.3 SUPPLY-SIDE ANALYSIS
FIGURE 5 R&D EXPENDITURE ON BIOTECHNOLOGY, BY COUNTRY, 2023 (USD BILLION)
2.3 MARKET SIZE ESTIMATION
2.3.1 APPROACH ONE (BASED ON APPLICATION, BY REGION)
2.3.2 APPROACH TWO (BASED ON GLOBAL MARKET)
2.4 DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 LIMITATIONS & RISK ASSESSMENT
2.7 RECESSION IMPACT ANALYSIS
2.7.1 MACRO-INDICATORS OF RECESSION
FIGURE 7 RECESSION INDICATORS
FIGURE 8 GLOBAL INFLATION RATE, 2013-2023
FIGURE 9 GLOBAL GROSS DOMESTIC PRODUCT, 2013-2023 (USD TRILLION)
FIGURE 10 RECESSION INDICATORS AND THEIR IMPACT ON SPECIALTY ENZYMES MARKET
FIGURE 11 SPECIALTY ENZYMES MARKET: CURRENT FORECAST VS. RECESSION FORECAST
3 EXECUTIVE SUMMARY
TABLE 2 SPECIALTY ENZYMES MARKET SNAPSHOT, 2024 VS. 2029
FIGURE 12 SPECIALTY ENZYMES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 13 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
FIGURE 14 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 34 LIST OF MAJOR PATENTS IN SPECIALTY ENZYMES MARKET
TABLE 8 LIST OF MAJOR PATENTS PUBLISHED, 2020-2024
6.10 KEY CONFERENCES & EVENTS, 2024-2025
TABLE 9 SPECIALTY ENZYMES MARKET: LIST OF KEY CONFERENCES & EVENTS, 2024-2025
6.11 REGULATORY LANDSCAPE
6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.2 REGULATIONS, BY REGION
6.11.2.1 North America
6.11.2.1.1 US
6.11.2.1.2 Canada
6.11.2.2 Europe
6.11.2.2.1 European Union
6.11.2.3 Asia Pacific
6.11.2.3.1 China
6.11.2.3.2 India
6.11.2.4 South America
6.11.2.4.1 Brazil
6.12 PORTER'S FIVE FORCES ANALYSIS
TABLE 14 SPECIALTY ENZYMES MARKET: PORTER'S FIVE FORCES ANALYSIS
6.12.1 INTENSITY OF COMPETITIVE RIVALRY
6.12.2 BARGAINING POWER OF SUPPLIERS
6.12.3 BARGAINING POWER OF BUYERS
6.12.4 THREAT OF SUBSTITUTES
6.12.5 THREAT OF NEW ENTRANTS
6.13 KEY STAKEHOLDERS & BUYING CRITERIA
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON PURCHASE OF SPECIALTY ENZYMES FROM VARIOUS SOURCES
TABLE 15 INFLUENCE OF STAKEHOLDERS ON PURCHASE OF ENZYMES FROM VARIOUS SOURCES
6.13.2 BUYING CRITERIA
TABLE 16 KEY BUYING CRITERIA FOR TOP FOUR SPECIALTY ENZYME APPLICATIONS
FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE SPECIALTY ENZYME APPLICATIONS
6.14 CASE STUDIES
6.14.1 BIOCATALYSTS ASSEMBLED MULTI-SKILLED PROJECT TEAM AND PRIORITIZED ON-SITE PRESENCE TO OVERCOME REMOTE WORKING CHALLENGES DURING COMMISSIONING PROCESS
6.14.2 CODEXIS DEPLOYED ITS CODEEVOLVER PLATFORM TO DEVELOP HIGHLY EFFICIENT AND STEREOSPECIFIC KETOREDUCTASE ENZYMES
6.14.3 THERMO FISHER SCIENTIFIC UTILIZED DIRECTED EVOLUTION TECHNIQUES TO ENGINEER NOVEL VARIANT OF PHI29 DNA POLYMERASE
6.15 INVESTMENT AND FUNDING SCENARIO
FIGURE 37 INVESTMENT AND FUNDING SCENARIO
7 SPECIALTY ENZYMES MARKET, BY TYPE
7.1 INTRODUCTION
FIGURE 38 SPECIALTY ENZYMES MARKET, BY TYPE, 2024 VS. 2029
TABLE 17 SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
TABLE 18 SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
TABLE 19 SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (KILOTONS)
TABLE 20 SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (KILOTONS)
7.2 CARBOHYDRASES
7.2.1 APPLICATIONS OF CARBOHYDRASES IN PHARMACEUTICAL, RESEARCH, AND BIOTECHNOLOGY SECTORS TO FUEL MARKET GROWTH
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 ADJACENT AND RELATED MARKETS
14.1 INTRODUCTION
TABLE 287 MARKETS ADJACENT TO SPECIALTY ENZYMES MARKET
14.2 LIMITATIONS
14.3 INDUSTRIAL ENZYMES MARKET
14.3.1 MARKET DEFINITION
14.3.2 MARKET OVERVIEW
TABLE 288 INDUSTRIAL ENZYMES MARKET, BY APPLICATION, 2019-2022 (USD MILLION)
TABLE 289 INDUSTRIAL ENZYMES MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
